| Biocon Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532523 |
NSE Symbol : BIOCON |
P/E(TTM) : 393.52 |
|
ISIN Demat : INE376G01013 |
Div & Yield% : 0.12 |
EPS(TTM) : 1.08 |
|
Book Value(₹) : 167.99 |
Market Cap(₹Cr) : 69,262.00 |
Face Value(₹) : 5.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 624.50 | 604.70 | 621.30 | 583.30 | 537.10 | 643.80 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 624.50 | 604.70 | 621.30 | 583.30 | 537.10 | 643.80 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 64.80 | 49.80 | 74.80 | 133.80 | 61.30 | 62.70 |
| Total Income | 689.30 | 654.50 | 696.10 | 717.10 | 598.40 | 706.50 |
| Total Expenditure | 563.70 | 544.20 | 744.30 | 530.40 | 516.50 | 581.80 |
| PBIDT | 125.60 | 110.30 | -48.20 | 186.70 | 81.90 | 124.70 |
| Interest | 17.30 | 16.70 | 2.30 | 67.20 | 56.20 | 56.70 |
| PBDT | 108.30 | 93.60 | -50.50 | 119.50 | 25.70 | 68.00 |
| Depreciation | 38.40 | 36.20 | 34.00 | 33.80 | 33.30 | 33.00 |
| Tax | 16.70 | -1.20 | 8.90 | 3.20 | 1.10 | 26.50 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.00 | 7.60 | -17.00 | 11.60 | -0.40 | -12.70 |
| Reported Profit After Tax | 52.20 | 51.00 | -76.40 | 70.90 | -8.30 | 21.20 |
| Extra-ordinary Items | 0.00 | -16.31 | -187.40 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 52.20 | 67.31 | 111.00 | 70.90 | -8.30 | 21.20 |
| EPS (Unit Curr.) | 0.32 | 0.32 | -0.57 | 0.55 | -0.07 | 0.18 |
| EPS (Adj) (Unit Curr.) | 0.32 | 0.32 | -0.57 | 0.55 | -0.07 | 0.18 |
| Calculated EPS (Unit Curr.) | 0.32 | 0.31 | -0.57 | 0.53 | -0.06 | 0.18 |
| Calculated EPS (Adj) (Unit Curr.) | 0.32 | 0.31 | -0.57 | 0.53 | -0.06 | 0.18 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.28 | 1.26 | -2.29 | 2.12 | -0.25 | 0.71 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.28 | 1.26 | -2.29 | 2.12 | -0.25 | 0.71 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 814.80 | 810.50 | 668.50 | 668.50 | 668.50 | 600.30 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 20.11 | 18.24 | -7.76 | 32.01 | 15.25 | 19.37 |
| PBDTM(%) | 17.34 | 15.48 | -8.13 | 20.49 | 4.78 | 10.56 |
| PATM(%) | 8.36 | 8.43 | -12.30 | 12.15 | -1.55 | 3.29 |
